Page last updated: 2024-12-06

n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-cyano-N'-(1,1-dimethylpropyl)-N''-(3-pyridinyl)guanidine: potassium channel opener [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID43345
CHEMBL ID11458
CHEBI ID92004
SCHEMBL ID2129487
SCHEMBL ID8747731
MeSH IDM0199651

Synonyms (56)

Synonym
HMS3394G15
HMS3267B04
BRD-K00206590-001-01-2
p 1075
n-cyano-n'-(1,1-dimethylpropyl)-n''-(3-pyridinyl)guanidine
guanidine, 2-cyano-1-tert-pentyl-3-(3-pyridyl)-
p-1075
guanidine, n-cyano-n'-(1,1-dimethylpropyl)-n''-3-pyridinyl-
brn 0480738
2-cyano-1-tert-pentyl-3-(3-pyridyl)guanidine
NCGC00025121-01
tocris-1355
MLS001424147
MLS000758317
guanidine, n-cyano-n'-(1,1-dimethylpropyl)-n''-3-pyridinyl- [cas]
smr000466288
p1075 ,
HMS2052G15
CHEMBL11458 ,
1-cyano-2-(2-methylbutan-2-yl)-3-pyridin-3-ylguanidine
3n-cyanoimino(tert-pentylamino)methyl-3-pyridinaminep1075)
n-cyano-n''''-(1,1-dimethylpropyl)-n''-pyridin-3-ylguanidine
bdbm50062397
n''''-cyano-n-(1,1-dimethylpropyl)-n''-pyridin-3-ylguanidine
3n-cyanoimino(tert-pentylamino)methyl-3-pyridinamine
u-83757
SCHEMBL2129487
nsc_43345
cas_60559-98-0
bdbm86250
HMS2232A04
CCG-101122
FT-0640699
ra77iz6b2f ,
unii-ra77iz6b2f
60559-98-0
HMS3371P02
NC00372
n-cyano-n-tert-pentyl-n'-3-pyridylguanidine
HKZNADVVGXKQDL-UHFFFAOYSA-N
SCHEMBL8747731
n-cyano-n'-(1,1-dimethylpropyl)-n''-3-pyridylguanidine
AKOS024456545
DTXSID60209335
SR-01000597574-1
sr-01000597574
CHEBI:92004
n-cyano-n'-(1,1-dimethylpropyl)-n'-3-pyridinyl-guanidine
1-cyano-2-(2-methylbutan-2-yl)-3-(3-pyridinyl)guanidine
Q27163801
pnu-83757
n-cyano-n'-(1,1-dimethyl-propyl)-n''-3-pyridinyl guanidine
CS-0029185
MS-23322
HY-108573
AKOS040742356

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" Dose-response effect of P-1075 on KATP channel had a Kd of 34."( A specific activator of the ATP-inhibited K+ channels in guinea pig ventricular cells.
Lee, KS; Tsai, TD; Xu, X, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyridinesAny organonitrogen heterocyclic compound based on a pyridine skeleton and its substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (29)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency89.12510.141337.9142100.0000AID1490
cytochrome P450 2D6 isoform 1Homo sapiens (human)Potency39.81070.00207.533739.8107AID891
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency5.01190.031610.279239.8107AID884; AID885
lethal factor (plasmid)Bacillus anthracis str. A2012Potency12.58930.020010.786931.6228AID912
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency5.01191.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP synthase subunit beta, mitochondrialBos taurus (cattle)IC50 (µMol)100.00000.48000.48000.4800AID68758
ATP synthase subunit delta, mitochondrialBos taurus (cattle)IC50 (µMol)100.00000.48000.48000.4800AID68758
ATP synthase subunit gamma, mitochondrialBos taurus (cattle)IC50 (µMol)100.00000.48000.48000.4800AID68758
ATP synthase subunit epsilon, mitochondrialBos taurus (cattle)IC50 (µMol)100.00000.48000.48000.4800AID68758
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)IC50 (µMol)100.00000.00031.38338.4000AID68758
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
ATP-binding cassette sub-family C member 9Homo sapiens (human)EC50 (µMol)0.07730.02190.70193.5400AID272328; AID272330; AID272331; AID347643; AID93974; AID93977; AID93984
ATP-binding cassette sub-family C member 8Homo sapiens (human)EC50 (µMol)0.05060.02191.12578.8000AID93974; AID93977; AID93984
ATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)EC50 (µMol)0.05190.02190.97088.8000AID272328; AID272330; AID272331; AID93974; AID93977; AID93984
ATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)EC50 (µMol)0.05060.02190.54852.7542AID93974; AID93977; AID93984
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (84)

Processvia Protein(s)Taxonomy
defense response to virusATP-binding cassette sub-family C member 9Homo sapiens (human)
action potentialATP-binding cassette sub-family C member 9Homo sapiens (human)
heart morphogenesisATP-binding cassette sub-family C member 9Homo sapiens (human)
response to xenobiotic stimulusATP-binding cassette sub-family C member 9Homo sapiens (human)
response to ATPATP-binding cassette sub-family C member 9Homo sapiens (human)
negative regulation of blood pressureATP-binding cassette sub-family C member 9Homo sapiens (human)
fibroblast proliferationATP-binding cassette sub-family C member 9Homo sapiens (human)
transmembrane transportATP-binding cassette sub-family C member 9Homo sapiens (human)
coronary vasculature developmentATP-binding cassette sub-family C member 9Homo sapiens (human)
cardiac conductionATP-binding cassette sub-family C member 9Homo sapiens (human)
potassium ion transmembrane transportATP-binding cassette sub-family C member 9Homo sapiens (human)
cardiac muscle cell contractionATP-binding cassette sub-family C member 9Homo sapiens (human)
monoatomic cation transmembrane transportATP-binding cassette sub-family C member 9Homo sapiens (human)
monoatomic anion transmembrane transportATP-binding cassette sub-family C member 9Homo sapiens (human)
inorganic cation transmembrane transportATP-binding cassette sub-family C member 9Homo sapiens (human)
transport across blood-brain barrierATP-binding cassette sub-family C member 9Homo sapiens (human)
potassium ion import across plasma membraneATP-binding cassette sub-family C member 9Homo sapiens (human)
proton transmembrane transportATP synthase subunit beta, mitochondrialBos taurus (cattle)
proton transmembrane transportATP synthase subunit delta, mitochondrialBos taurus (cattle)
aerobic respirationATP synthase subunit delta, mitochondrialBos taurus (cattle)
mitochondrial proton-transporting ATP synthase complex assemblyATP synthase subunit delta, mitochondrialBos taurus (cattle)
proton transmembrane transportATP synthase subunit gamma, mitochondrialBos taurus (cattle)
proton transmembrane transportATP synthase subunit epsilon, mitochondrialBos taurus (cattle)
intracellular glucose homeostasisATP-binding cassette sub-family C member 8Homo sapiens (human)
potassium ion transportATP-binding cassette sub-family C member 8Homo sapiens (human)
female pregnancyATP-binding cassette sub-family C member 8Homo sapiens (human)
memoryATP-binding cassette sub-family C member 8Homo sapiens (human)
visual learningATP-binding cassette sub-family C member 8Homo sapiens (human)
response to pHATP-binding cassette sub-family C member 8Homo sapiens (human)
response to xenobiotic stimulusATP-binding cassette sub-family C member 8Homo sapiens (human)
response to zinc ionATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of low-density lipoprotein particle clearanceATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of angiogenesisATP-binding cassette sub-family C member 8Homo sapiens (human)
response to lipopolysaccharideATP-binding cassette sub-family C member 8Homo sapiens (human)
positive regulation of tumor necrosis factor productionATP-binding cassette sub-family C member 8Homo sapiens (human)
response to insulinATP-binding cassette sub-family C member 8Homo sapiens (human)
positive regulation of insulin secretion involved in cellular response to glucose stimulusATP-binding cassette sub-family C member 8Homo sapiens (human)
positive regulation of potassium ion transportATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of insulin secretionATP-binding cassette sub-family C member 8Homo sapiens (human)
neuromuscular processATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of glial cell proliferationATP-binding cassette sub-family C member 8Homo sapiens (human)
glutamate secretion, neurotransmissionATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of neuroblast migrationATP-binding cassette sub-family C member 8Homo sapiens (human)
cellular response to organic substanceATP-binding cassette sub-family C member 8Homo sapiens (human)
potassium ion transmembrane transportATP-binding cassette sub-family C member 8Homo sapiens (human)
inorganic cation transmembrane transportATP-binding cassette sub-family C member 8Homo sapiens (human)
positive regulation of uterine smooth muscle relaxationATP-binding cassette sub-family C member 8Homo sapiens (human)
positive regulation of tight junction disassemblyATP-binding cassette sub-family C member 8Homo sapiens (human)
negative regulation of blood-brain barrier permeabilityATP-binding cassette sub-family C member 8Homo sapiens (human)
potassium ion import across plasma membraneATP-binding cassette sub-family C member 8Homo sapiens (human)
transmembrane transportATP-binding cassette sub-family C member 8Homo sapiens (human)
action potentialATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to hypoxiaATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to ischemiaATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
ventricular cardiac muscle tissue developmentATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
glucose metabolic processATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
apoptotic processATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
determination of adult lifespanATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to xenobiotic stimulusATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to estradiolATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to ATPATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to testosteroneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
regulation of membrane potentialATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
negative regulation of insulin secretionATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
regulation of insulin secretionATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
nervous system processATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
CAMKK-AMPK signaling cascadeATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
cellular response to nicotineATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
cellular response to glucose stimulusATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
cellular response to tumor necrosis factorATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
potassium ion transmembrane transportATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
inorganic cation transmembrane transportATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
regulation of presynaptic membrane potentialATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
positive regulation of protein localization to plasma membraneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to resveratrolATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
potassium ion import across plasma membraneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
regulation of monoatomic ion transmembrane transportATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
response to hypoxiaATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
microglial cell activationATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
kidney developmentATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
regulation of heart rateATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
adaptive immune responseATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
response to ischemiaATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
heart morphogenesisATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
ventricular cardiac muscle tissue developmentATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
potassium ion transportATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
apoptotic processATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
regulation of blood pressureATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
determination of adult lifespanATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
protein secretionATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
response to xenobiotic stimulusATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
gene expressionATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
fatty acid transportATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
transmission of nerve impulseATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
establishment of cell polarityATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
response to lipopolysaccharideATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
response to insulinATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
response to ATPATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
response to cytokineATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
response to endoplasmic reticulum stressATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
p38MAPK cascadeATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
vasodilationATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
response to exogenous dsRNAATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
NLRP3 inflammasome complex assemblyATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
fat cell differentiationATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
fibroblast proliferationATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
neuromuscular processATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
synaptic assembly at neuromuscular junctionATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
defense response to virusATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
atrioventricular node cell differentiationATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
coronary vasculature developmentATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
glutamate secretion, neurotransmissionATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
CAMKK-AMPK signaling cascadeATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
calcium ion transmembrane transportATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
potassium ion transmembrane transportATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
inorganic cation transmembrane transportATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
membrane repolarization during ventricular cardiac muscle cell action potentialATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
regulation of presynaptic membrane potentialATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
reactive gliosisATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
transport across blood-brain barrierATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
response to resveratrolATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
potassium ion import across plasma membraneATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
regulation of monoatomic ion transmembrane transportATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (25)

Processvia Protein(s)Taxonomy
monoatomic cation channel activityATP-binding cassette sub-family C member 9Homo sapiens (human)
potassium channel activityATP-binding cassette sub-family C member 9Homo sapiens (human)
ATP-activated inward rectifier potassium channel activityATP-binding cassette sub-family C member 9Homo sapiens (human)
transmembrane transporter activityATP-binding cassette sub-family C member 9Homo sapiens (human)
ATP bindingATP-binding cassette sub-family C member 9Homo sapiens (human)
sulfonylurea receptor activityATP-binding cassette sub-family C member 9Homo sapiens (human)
potassium channel regulator activityATP-binding cassette sub-family C member 9Homo sapiens (human)
ATP hydrolysis activityATP-binding cassette sub-family C member 9Homo sapiens (human)
ATPase-coupled monoatomic cation transmembrane transporter activityATP-binding cassette sub-family C member 9Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-binding cassette sub-family C member 9Homo sapiens (human)
ATPase-coupled inorganic anion transmembrane transporter activityATP-binding cassette sub-family C member 9Homo sapiens (human)
transmembrane transporter bindingATP-binding cassette sub-family C member 9Homo sapiens (human)
ABC-type transporter activityATP-binding cassette sub-family C member 9Homo sapiens (human)
protein bindingATP synthase subunit beta, mitochondrialBos taurus (cattle)
ATP bindingATP synthase subunit beta, mitochondrialBos taurus (cattle)
ATP hydrolysis activityATP synthase subunit beta, mitochondrialBos taurus (cattle)
proton-transporting ATPase activity, rotational mechanismATP synthase subunit beta, mitochondrialBos taurus (cattle)
proton transmembrane transporter activityATP synthase subunit delta, mitochondrialBos taurus (cattle)
protein bindingATP synthase subunit gamma, mitochondrialBos taurus (cattle)
ATP-activated inward rectifier potassium channel activityATP-binding cassette sub-family C member 8Homo sapiens (human)
potassium channel activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ATP bindingATP-binding cassette sub-family C member 8Homo sapiens (human)
sulfonylurea receptor activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ATP-activated inward rectifier potassium channel activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ATP hydrolysis activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ATPase-coupled monoatomic cation transmembrane transporter activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ADP bindingATP-binding cassette sub-family C member 8Homo sapiens (human)
transmembrane transporter bindingATP-binding cassette sub-family C member 8Homo sapiens (human)
ABC-type transporter activityATP-binding cassette sub-family C member 8Homo sapiens (human)
ATPase-coupled transmembrane transporter activityATP-binding cassette sub-family C member 8Homo sapiens (human)
voltage-gated potassium channel activityATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
protein bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
ATP bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
ATP-activated inward rectifier potassium channel activityATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
ATPase-coupled monoatomic cation transmembrane transporter activityATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
ankyrin bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
potassium ion bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
heat shock protein bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
transmembrane transporter bindingATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
inward rectifier potassium channel activityATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
protein bindingATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
ATP bindingATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
ATP-activated inward rectifier potassium channel activityATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
sulfonylurea receptor bindingATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
ATPase-coupled monoatomic cation transmembrane transporter activityATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarizationATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (24)

Processvia Protein(s)Taxonomy
plasma membraneATP-binding cassette sub-family C member 9Homo sapiens (human)
sarcomereATP-binding cassette sub-family C member 9Homo sapiens (human)
inward rectifying potassium channelATP-binding cassette sub-family C member 9Homo sapiens (human)
potassium ion-transporting ATPase complexATP-binding cassette sub-family C member 9Homo sapiens (human)
membraneATP-binding cassette sub-family C member 9Homo sapiens (human)
mitochondrial proton-transporting ATP synthase complexATP synthase subunit beta, mitochondrialBos taurus (cattle)
mitochondrial envelopeATP synthase subunit delta, mitochondrialBos taurus (cattle)
mitochondrial proton-transporting ATP synthase complexATP synthase subunit delta, mitochondrialBos taurus (cattle)
proton-transporting ATP synthase complexATP synthase subunit delta, mitochondrialBos taurus (cattle)
mitochondrial proton-transporting ATP synthase complexATP synthase subunit gamma, mitochondrialBos taurus (cattle)
mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1)ATP synthase subunit epsilon, mitochondrialBos taurus (cattle)
mitochondrial proton-transporting ATP synthase complexATP synthase subunit epsilon, mitochondrialBos taurus (cattle)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
plasma membraneATP-binding cassette sub-family C member 8Homo sapiens (human)
inward rectifying potassium channelATP-binding cassette sub-family C member 8Homo sapiens (human)
synaptic vesicle membraneATP-binding cassette sub-family C member 8Homo sapiens (human)
sarcolemmaATP-binding cassette sub-family C member 8Homo sapiens (human)
potassium ion-transporting ATPase complexATP-binding cassette sub-family C member 8Homo sapiens (human)
membraneATP-binding cassette sub-family C member 8Homo sapiens (human)
acrosomal vesicleATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
nuclear envelopeATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
endosomeATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
plasma membraneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
inward rectifying potassium channelATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
intercalated discATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
T-tubuleATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
axolemmaATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
presynaptic membraneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
neuronal cell bodyATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
cell body fiberATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
glutamatergic synapseATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
plasma membraneATP-sensitive inward rectifier potassium channel 11Homo sapiens (human)
plasma membraneATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
myofibrilATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
sarcolemmaATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
presynaptic active zone membraneATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
glutamatergic synapseATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
voltage-gated potassium channel complexATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
inward rectifying potassium channelATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
potassium ion-transporting ATPase complexATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
plasma membraneATP-sensitive inward rectifier potassium channel 8Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (58)

Assay IDTitleYearJournalArticle
AID1148589Hypotensive activity in po dosed spontaneously hypertensive Wistar-Okamoto rat relative to guancydine1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID1148551Toxicity in po dosed Sprague-Dawley rat assessed as mortality after 7 days1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID197525Concentration required to cause 50% inhibition of spontaneous activity in rat portal vein1992Journal of medicinal chemistry, Jun-12, Volume: 35, Issue:12
Structure-activity studies of potassium channel opening in pinacidil-type cyanoguanidines, nitroethenediamines, thioureas, and ureas.
AID93977Evaluated for K-ATP activity in terms of stable twitch response through field-stimulated landrace pig detrusor assay2004Journal of medicinal chemistry, Jun-03, Volume: 47, Issue:12
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)
AID1148566Hypotensive activity in spontaneously hypertensive Wistar-Okamoto rat assessed as time required for persistence of hypotensive effect at 0.1 mg/kg, po1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID347645Channel opening activity at SUR1/Kir6.2 potassium ATP channel in mouse beta-TC6 cells assessed as isometric force by FLIPR2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
AID1148550Hypotensive activity in po dosed spontaneously hypertensive Wistar-Okamoto rat assessed as dose required to cause 30 mmHg fall of blood pressure administered for 5 days1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID272331Activity against pig bladder KATP channel opening assessed as ability to relax spontaneous bladder contraction2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
AID180316Inhibitory concentration against methoxamine-induced contractions in rat aorta1998Journal of medicinal chemistry, Jan-29, Volume: 41, Issue:3
Binding of ATP-sensitive potassium channel (KATP) openers to cardiac membranes: correlation of binding affinities with cardioprotective and smooth muscle relaxing potencies.
AID175306Effective concentration required to increase time to the onset of contracture (TTC) in globally ischemic rat hearts1998Journal of medicinal chemistry, Jan-29, Volume: 41, Issue:3
Binding of ATP-sensitive potassium channel (KATP) openers to cardiac membranes: correlation of binding affinities with cardioprotective and smooth muscle relaxing potencies.
AID1148596Vasodilatory activity in conscious normotensive dog assessed as change in heart rate at 0.1 mg/kg, po1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID29396Ionisation constant (pKa2) due to proton loss from the pyridine ring1992Journal of medicinal chemistry, Jun-12, Volume: 35, Issue:12
Structure-activity studies of potassium channel opening in pinacidil-type cyanoguanidines, nitroethenediamines, thioureas, and ureas.
AID93974Evaluated for K-ATP activity in terms of change in membrane potential through guinea pig bladder assay2004Journal of medicinal chemistry, Jun-03, Volume: 47, Issue:12
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)
AID437030Cardioprotective effect in Langendorff perfused isolated rat hearts assessed as reduction in ischemic injury2009Bioorganic & medicinal chemistry, Aug-01, Volume: 17, Issue:15
Predictive models, based on classification algorithms, for compounds potentially active as mitochondrial ATP-sensitive potassium channel openers.
AID272346Activity against pig bladder KATP channel opening assessed as ability to relax field-stimulated pig detrusor relative to P10752006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
AID233874Selectivity expressed as the ratio of pEC50 (SLPD) and pEC50 (FSLPD)2004Journal of medicinal chemistry, Jun-03, Volume: 47, Issue:12
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)
AID272328Ability to open human urinary bladder Kir6.2 channel containing SUR2B in Ltk cells by FLIPR assay2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
AID68761IInhibitory concentration towards rat mitochondrial F1F0-ATP synthase using a hexokinase / glucose-6-phosphate dehydrogenase coupled assay; ND = not determined2004Journal of medicinal chemistry, Feb-26, Volume: 47, Issue:5
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors.
AID1148565Hypotensive activity in spontaneously hypertensive Wistar-Okamoto rat assessed as time required for persistence of hypotensive effect at 0.05 mg/kg, po1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID1148564Hypotensive activity in spontaneously hypertensive Wistar-Okamoto rat assessed as time required for persistence of hypotensive effect at 0.01 mg/kg, po1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID272329Ability to open human urinary bladder Kir6.2 containing SUR2B in Ltk cells by FLIPR assay relative to P10752006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
AID48985Binding affinity was determined by displacement of [3H]P1075 from its binding sites in canine cardiac membranes1998Journal of medicinal chemistry, Jan-29, Volume: 41, Issue:3
Binding of ATP-sensitive potassium channel (KATP) openers to cardiac membranes: correlation of binding affinities with cardioprotective and smooth muscle relaxing potencies.
AID1148583Hypotensive activity in conscious renal hypertensive dog assessed as time required for persistence of hypotensive effect at 0.1 mg/kg, po measured for 8 hrs1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID195192In vitro ability to relax phenylephrine contracted rat aorta rings2001Bioorganic & medicinal chemistry letters, Jul-09, Volume: 11, Issue:13
Phenylcyanoguanidines as inhibitors of glucose-induced insulin secretion from beta cells.
AID1148611Toxicity in rat assessed as effect on contraction of nictitating membranes by preganglionic stimulation1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID347648Selectivity ratio of EC50 for african green monkey SUR2A/Kir6.2 potassium ATP channel to human SUR2B/Kir6.2 potassium ATP channel2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
AID272347Activity against pig bladder KATP channel opening assessed as ability to relax spontaneous bladder contraction relative to P10752006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
AID1148556Hypotensive activity in spontaneously hypertensive Wistar-Okamoto rat assessed as maximum change in mean blood pressure at 0.05 mg/kg, po relative to control1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID347649Vasorelaxant activity in rat bladder assessed as inhibition of carbachol-induced contraction2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
AID1148549Toxicity in po dosed mouse assessed as mortality after 7 days1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID347647Selectivity ratio of EC50 for mouse SUR1/Kir6.2 potassium ATP channel to human SUR2B/Kir6.2 potassium ATP channel2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
AID226482Hill Coefficient calculated by curve fitting of data to a single binding site model1998Journal of medicinal chemistry, Jan-29, Volume: 41, Issue:3
Binding of ATP-sensitive potassium channel (KATP) openers to cardiac membranes: correlation of binding affinities with cardioprotective and smooth muscle relaxing potencies.
AID68758Inhibitory concentration towards rat mitochondrial F1F0 ATP hydrolase using a pyruvate kinase / lactate dehydrogenase system2004Journal of medicinal chemistry, Feb-26, Volume: 47, Issue:5
Small molecule mitochondrial F1F0 ATPase hydrolase inhibitors as cardioprotective agents. Identification of 4-(N-arylimidazole)-substituted benzopyran derivatives as selective hydrolase inhibitors.
AID197347Concentration required to cause 15% increase in [86Rb+] efflux from rat portal vein.1992Journal of medicinal chemistry, Jun-12, Volume: 35, Issue:12
Structure-activity studies of potassium channel opening in pinacidil-type cyanoguanidines, nitroethenediamines, thioureas, and ureas.
AID347646Channel opening activity at SUR2A/Kir6.2 potassium ATP channel in african green monkey COS7 cells assessed as isometric force by FLIPR2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
AID190149The hypotensive activity expressed as rating of therapeutic index (MED/LD50 <1/200).1980Journal of medicinal chemistry, Jan, Volume: 23, Issue:1
Adaptive least-squares method applied to structure--activity correlation of hypotensive N-alkyl-N''-cyano-N'-pyridylguanidines.
AID1148555Hypotensive activity in spontaneously hypertensive Wistar-Okamoto rat assessed as maximum change in mean blood pressure at 0.01 mg/kg, po relative to control1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID1148600Vasodilatory activity in conscious normotensive dog assessed as cardiac output at 0.1 mg/kg, po by thermodilution method1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID161275Binding affinity towards potassium channel of rat aorta using [3H]15 as radioligand1993Journal of medicinal chemistry, Jul-09, Volume: 36, Issue:14
Synthesis of and radioligand binding studies with a tritiated pinacidil analogue: receptor interactions of structurally different classes of potassium channel openers and blockers.
AID1148609Toxicity in rat assessed as change in cardiac noradrenaline level at 0.1 mg/kg for 5 days1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID93984Evaluated for K-ATP activity as in vitro bladder relaxation in spontaneous Landrace pig detrusor strips (SLPD)2004Journal of medicinal chemistry, Jun-03, Volume: 47, Issue:12
Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)
AID1148582Hypotensive activity in conscious renal hypertensive dog assessed as time required for persistence of hypotensive effect at 0.05 mg/kg, po measured for 8 hrs1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID272330Activity against pig bladder KATP channel opening assessed as ability to relax field-stimulated pig detrusor2006Journal of medicinal chemistry, Nov-16, Volume: 49, Issue:23
Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener.
AID347643Channel opening activity at SUR2B/Kir6.2 potassium ATP channel in human TE671 cells assessed as isometric force by FLIPR2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Discovery and structure-activity relationships of a novel series of benzopyran-based K(ATP) openers for urge urinary incontinence.
AID1148592Vasodilatory activity in conscious normotensive dog assessed as change in blood pressure at 0.1 mg/kg, po1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID1148573Hypotensive activity in conscious renal hypertensive dog assessed as maximum change in mean blood pressure at 0.05 mg/kg, po measured for 8 hrs relative to control1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID1148557Hypotensive activity in spontaneously hypertensive Wistar-Okamoto rat assessed as maximum change in mean blood pressure at 0.1 mg/kg, po relative to control1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID1148590Hypotensive activity in decerebrated cat1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID228165Vasorelaxant activity expressed as negative logarithm of the concentration causing a 50% inhibition of spontaneous myogenic activity in rat portal vein.1993Journal of medicinal chemistry, Jul-09, Volume: 36, Issue:14
Synthesis of and radioligand binding studies with a tritiated pinacidil analogue: receptor interactions of structurally different classes of potassium channel openers and blockers.
AID29374Ionisation constant (pKa1) due to protonation of the pyridyl ring1992Journal of medicinal chemistry, Jun-12, Volume: 35, Issue:12
Structure-activity studies of potassium channel opening in pinacidil-type cyanoguanidines, nitroethenediamines, thioureas, and ureas.
AID1148574Hypotensive activity in conscious renal hypertensive dog assessed as maximum change in mean blood pressure at 0.1 mg/kg, po measured for 8 hrs relative to control1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID1148604Vasodilatory activity in conscious normotensive dog assessed as total peripheral resistance at 0.1 mg/kg, po1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID1148607Toxicity in rat assessed as change in cardiac noradrenaline level at 0.1 mg/kg1978Journal of medicinal chemistry, Aug, Volume: 21, Issue:8
Synthesis and hypotensive activity of N-alkyl-N"-cyano-N'-pyridylguanidines.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (86)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (2.33)18.7374
1990's37 (43.02)18.2507
2000's37 (43.02)29.6817
2010's8 (9.30)24.3611
2020's2 (2.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.47 (24.57)
Research Supply Index4.48 (2.92)
Research Growth Index5.94 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other87 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]